AbbVie ABBV
NYSE ABBV
$288.32 -6.51 (-2.21%)
As of: Nov 5, 2026 · 3:59 PM EST

AbbVie (ABBV) Liabilities and Shareholders Equity (2012 - 2026)

Updated

Analysis

AbbVie (ABBV) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn 197.43 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn 147.68 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn 119.92 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn 205.00 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn 32.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 147.68 Bn
Jun 30, 2026 135.12 Bn
Mar 31, 2026 136.46 Bn
Dec 31, 2025 133.96 Bn
Sep 30, 2025 133.90 Bn
Jun 30, 2025 137.18 Bn
Mar 31, 2025 136.17 Bn
Dec 31, 2024 135.16 Bn
Sep 30, 2024 143.42 Bn
Jun 30, 2024 141.94 Bn
Mar 31, 2024 148.87 Bn
Dec 31, 2023 134.71 Bn
Sep 30, 2023 136.22 Bn
Jun 30, 2023 135.37 Bn
Mar 31, 2023 134.54 Bn
Dec 31, 2022 138.81 Bn
Sep 30, 2022 141.33 Bn
Jun 30, 2022 143.19 Bn
Mar 31, 2022 143.21 Bn
Dec 31, 2021 146.53 Bn
API Access

AbbVie Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABBV&period=max&api_key=YOUR_API_KEY